These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 28567523)

  • 1. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.
    Tradtrantip L; Yao X; Su T; Smith AJ; Verkman AS
    Acta Neuropathol; 2017 Jul; 134(1):35-44. PubMed ID: 28567523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica.
    Duan T; Smith AJ; Verkman AS
    J Neuroinflammation; 2018 Oct; 15(1):294. PubMed ID: 30348195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity.
    Duan T; Smith AJ; Verkman AS
    Acta Neuropathol Commun; 2019 Jul; 7(1):112. PubMed ID: 31296268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.
    Yao X; Verkman AS
    Acta Neuropathol Commun; 2017 Feb; 5(1):15. PubMed ID: 28212662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
    Marignier R; Nicolle A; Watrin C; Touret M; Cavagna S; Varrin-Doyer M; Cavillon G; Rogemond V; Confavreux C; Honnorat J; Giraudon P
    Brain; 2010 Sep; 133(9):2578-91. PubMed ID: 20688809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
    Kira J
    Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.
    Tradtrantip L; Felix CM; Spirig R; Morelli AB; Verkman AS
    Neuropharmacology; 2018 May; 133():345-353. PubMed ID: 29428821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.
    Yao X; Verkman AS
    Acta Neuropathol Commun; 2017 Jul; 5(1):57. PubMed ID: 28750658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.
    Takai Y; Misu T; Suzuki H; Takahashi T; Okada H; Tanaka S; Okita K; Sasou S; Watanabe M; Namatame C; Matsumoto Y; Ono H; Kaneko K; Nishiyama S; Kuroda H; Nakashima I; Lassmann H; Fujihara K; Itoyama Y; Aoki M
    Brain; 2021 Sep; 144(8):2401-2415. PubMed ID: 33711152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of membrane complement regulators in neuromyelitis optica.
    Saadoun S; Papadopoulos MC
    Mult Scler; 2015 Nov; 21(13):1644-54. PubMed ID: 25698168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination.
    Liu Y; Given KS; Harlow DE; Matschulat AM; Macklin WB; Bennett JL; Owens GP
    Acta Neuropathol Commun; 2017 Mar; 5(1):25. PubMed ID: 28340598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica.
    Soltys J; Liu Y; Ritchie A; Wemlinger S; Schaller K; Schumann H; Owens GP; Bennett JL
    J Clin Invest; 2019 Apr; 129(5):2000-2013. PubMed ID: 30958797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
    Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
    J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica.
    Tradtrantip L; Duan T; Yeaman MR; Verkman AS
    J Neuroinflammation; 2019 Mar; 16(1):57. PubMed ID: 30851734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO.
    Verkman AS; Phuan PW; Asavapanumas N; Tradtrantip L
    Brain Pathol; 2013 Nov; 23(6):684-95. PubMed ID: 24118484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment.
    Vincent T; Saikali P; Cayrol R; Roth AD; Bar-Or A; Prat A; Antel JP
    J Immunol; 2008 Oct; 181(8):5730-7. PubMed ID: 18832732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
    Ratelade J; Asavapanumas N; Ritchie AM; Wemlinger S; Bennett JL; Verkman AS
    Acta Neuropathol; 2013 Nov; 126(5):699-709. PubMed ID: 23995423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica.
    Liu Y; Harlow DE; Given KS; Owens GP; Macklin WB; Bennett JL
    J Neuroinflammation; 2016 Dec; 13(1):301. PubMed ID: 27905992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.